Please assess the completion status of the following clinical trial:

Trial Title: Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed CF diagnosis by two positive chloride sweat tests or gene analysis~* Confirmed PEI by historical Coefficient of fat Absorption \< 70% without supplementation or current or historical fecal elastase \< 50µg/stool (within the last 12 months)~* Currently receiving treatment with a commercially available pancreatic enzyme product on a stable dose for more than 3 months~* Clinically stable condition without evidence of acute respiratory disease or any other acute condition~* Stable body weight and agrees to abstain from sexual activity~Exclusion Criteria:~* Ileus or acute abdomen~* History of fibrosing colonopathy, celiac disease, gastrectomy, Crohn´s disease and small bowel surgery other than minor resection due to meconium ileus without resulting in malabsorption syndrome~* History of distal ileal obstruction syndrome within 6 months of enrollment~* Use of an immunosuppressive drug~* Any type of malignancy involving the digestive tract in the last 5 years~* Known infection with HIV

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).